3-5
2026
影响因子区间
159天
平台估算
29%
2025
中国作者发文占比
—
收费
期刊简介:Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.
【译文】在新任编辑团队的领导下,《实验与分子病理学》期刊发表关于哺乳动物组织和液体中疾病过程与结构及生化改变相关的研究文章,以及将分子生物学的新技术应用于人类和其他动物病理问题的应用文章。该期刊还发表来自病理学当代研究前沿的实验研究人员的精选解释性综述。此外,特别主题问题还呈现解开自然界最严格保守的秘密——疾病病理基础的研究报告。研究领域包括:干细胞;新生血管生成;分子诊断;聚合酶链反应;原位杂交;DNA测序;细胞受体;致癌作用;肿瘤病理学;复杂传染病;移植;细胞因子;流式细胞术分析;炎症;细胞损伤;免疫学和超敏反应;动脉粥样硬化。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |